Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Diagnocure Inc. (CUR.TO)
Financials 
Technical Analysis 0
TOP PICK
Has a test on the market for bladder testing for cancer. Now working with a US company, Gen-Probe, to develop a prostrate diagnostic test for the US and world markets. Tests are 90% accurate compared to the PSA tests which are only right once out of four times. Have also just announced testing for lung cancer with high accuracy figures.
Jean-Francois TardifOwned
biotechnologypharmaceutical
Showing 1 to 1 of 1 entries
- «
- ‹
- 1
- ›
- »
Diagnocure Inc. (CUR.TO) Frequently Asked Questions
What is Diagnocure Inc. stock symbol?
Diagnocure Inc. is a OTC stock, trading under the symbol CUR.TO (previously CUR-T on Stockchase) on the undefined (undefined). It is usually referred to as or CUR.TO
Is Diagnocure Inc. a buy or a sell?
In the last year, no analyst issued a Buy, Sell, or Hold rating on CUR.TO (previously CUR-T on Stockchase) on Stockchase. Read the latest expert commentary for Diagnocure Inc..
Is Diagnocure Inc. a good investment or a top pick?
Diagnocure Inc. was recommended as a Top Pick by Jean-Francois Tardif on 2004-12-03. Read the latest stock experts ratings for Diagnocure Inc..
Why is Diagnocure Inc. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Diagnocure Inc..
Is Diagnocure Inc. worth watching?
Diagnocure Inc. is covered by Stockchase experts and is worth watching.
